Zócalo Health | $15,000,000 | (Apr 24, 2026)
Rilian | $17,500,000 | (Apr 24, 2026)
BAND | $17,000,000 | (Apr 24, 2026)
Certified by Founder
Lodge
Antiverse
start up
United Kingdom
- Cardiff, Wales
- 03/03/2023
- Unknown
- $3,000,000
Antiverse is building a world-first computational antibody drug discovery platform. We combine in-house lab expertise with state of the art machine learning to predict antibody-antigen binding and provide antibody drug candidates in weeks.
- Industry Pharmaceutical Manufacturing
- Website https://www.antiverse.io/
- LinkedIn https://www.linkedin.com/company/antiverse/
Related People
Murat TunaboyluFounder
United Kingdom -
Cardiff, Wales
CEO of Antiverse, background in software engineering and bioinformatics. Mid-career developed high-frequency trading systems. After switching to biotech, built cell imaging software and lab robots to accelerate cancer research and automated Thermo Fisher Scientific’s gene synthesis workflows. Co-founded consultancy and biotech companies Svarlight and Antiverse.
Currently focusing on to realise Antiverse’s mission: engineering the future of drug discovery.
Brev.io | $3,300,000 | (Apr 24, 2026)
Maxed | $850,000 | (Apr 24, 2026)
Omni | $120,000,000 | (Apr 24, 2026)
VREY | $3,859,432 | (Apr 24, 2026)
Astor (YC S25) | $5,000,000 | (Apr 24, 2026)
QMatter | $1,200,000 | (Apr 24, 2026)
Almanac Health | $10,000,000 | (Apr 24, 2026)
Petual | $20,000,000 | (Apr 24, 2026)
C-Infinity | $16,000,000 | (Apr 23, 2026)